Clinical Evaluation of Opti-Free III (FID 109182) Compared to Opti-Free Plus® in Japan

NCT ID: NCT02251561

Last Updated: 2015-06-10

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-11-30

Study Completion Date

2014-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare an investigational contact lens care product (FID 109182) to a commercially available contact lens product (Opti-Free Plus®) for corneal staining when used with Acuvue® Oasys® contact lenses. The contact lenses will be pre-soaked in the products for 24-48 hours prior to a 2-hour contralateral wear period.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Corneal Staining

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

FID 109182

Senofilcon A contact lens pre-soaked in FID 109182 worn in the right or left eye as randomized for 2 hours

Group Type EXPERIMENTAL

FID 109182

Intervention Type DEVICE

Investigational multipurpose contact lens cleaning and disinfecting solution

Senofilcon A contact lens

Intervention Type DEVICE

Commercially available silicone hydrogel contact lens

Opti-Free Plus

Senofilcon A contact lens pre-soaked in Opti-Free Plus worn in the fellow eye for 2 hours

Group Type ACTIVE_COMPARATOR

Opti-Free Plus

Intervention Type DEVICE

Commercially available multipurpose contact lens cleaning and disinfecting solution

Senofilcon A contact lens

Intervention Type DEVICE

Commercially available silicone hydrogel contact lens

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

FID 109182

Investigational multipurpose contact lens cleaning and disinfecting solution

Intervention Type DEVICE

Opti-Free Plus

Commercially available multipurpose contact lens cleaning and disinfecting solution

Intervention Type DEVICE

Senofilcon A contact lens

Commercially available silicone hydrogel contact lens

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Opti-Free III Opti-Free Plus® Acuvue® Oasys®

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Soft contact lenses habitual wearer, both eyes.
* Voluntarily sign Informed Consent.

Exclusion Criteria

* Unable to tolerate the ingredients in Opti-Free® and similar contact lens care products.
* Potential use of eye drops during the study, including over-the-counter products, except for artificial tear eye drops.
* Eye infection, blepharitis, iris inflammation, or severe eye inflammation.
* Corneal staining greater than Grade 1 at baseline.
* Pregnant, lactating, or intend to become pregnant during study period.
Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alcon Research

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tsunemitsu Senta

Role: STUDY_DIRECTOR

Alcon Japan, Ltd.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CVKK2013-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

OPTI-FREE Family STUDY
NCT06592521 WITHDRAWN NA